Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27,776 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with EGFR sensitive mutant non-small cell lung cancer in a Real world population.
Zeng L, Xiao L, Jiang W, Yang H, Hu D, Xia C, Li Y, Zhou C, Xiong Y, Liu L, Liao D, Guan R, Li K, Wang J, Zhang Y, Yang N, Mansfield AS. Zeng L, et al. Among authors: li y, li k. Lung Cancer. 2020 Mar;141:82-88. doi: 10.1016/j.lungcan.2020.01.009. Epub 2020 Jan 13. Lung Cancer. 2020. PMID: 31982639
Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer.
Peng X, Long X, Liu L, Zeng L, Yang H, Jiang W, Liao D, Li K, Wang J, Lizaso A, Mao X, Xu Q, Mansfield AS, Yang N, Zhang Y. Peng X, et al. Among authors: li k. Eur J Cancer. 2020 Dec;141:199-208. doi: 10.1016/j.ejca.2020.10.005. Epub 2020 Nov 7. Eur J Cancer. 2020. PMID: 33171317
Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non-Small Cell Lung Cancer After Second-Line Treatment Failure: A Nonrandomized Clinical Trial.
Zhang X, Xiong Y, Xia Q, Wu F, Liu L, Zhou Y, Zeng L, Zhou C, Xia C, Jiang W, Liao D, Xiao L, Liu L, Yang H, Guan R, Li K, Wang J, Lei G, Zhang Y, Yang N. Zhang X, et al. Among authors: li k. JAMA Netw Open. 2020 Mar 2;3(3):e201226. doi: 10.1001/jamanetworkopen.2020.1226. JAMA Netw Open. 2020. PMID: 32191330 Free PMC article. Clinical Trial.
Corrigendum to ' Evaluation of the pharmacokinetic effects of itraconazole on alflutinib (AST2818): an open-label, single-center, single-sequence, two-period randomized study in healthy volunteers'[European Journal of Pharmaceutical Sciences 162 (2021) 105815].
Heng J, Tang Q, Chen X, Bao J, Deng J, Chen Y, Zhao J, Zhu S, Liu X, Yang F, Jiang Y, Yang N, Li K. Heng J, et al. Among authors: li k. Eur J Pharm Sci. 2022 Apr 1;171:106143. doi: 10.1016/j.ejps.2022.106143. Epub 2022 Feb 16. Eur J Pharm Sci. 2022. PMID: 35181200 Free article. No abstract available.
27,776 results
You have reached the last available page of results. Please see the User Guide for more information.